Cholera media information

PLEASE NOTE: All assets on this page are intended for use by U.S. and Canada media professionals only.

---

September 16, 2024

Bavarian Nordic recently announced commercial availability of VAXCHORA^® (Cholera Vaccine, Live Attenuated, Oral) in Canada.

Approved in Australia, the United Kingdom, the European Union, and the United States, VAXCHORA is the only single-dose cholera vaccine approved in Canada and is the only FDA-approved cholera vaccine in the U.S. to help protect against cholera, a sudden and serious intestinal infection marked by acute watery diarrhea.

Read more in the press release below.

---